Dear Colleagues,
We are pleased to invite you to join us on 27 February 2025 at 17:00 CET for a joint TBnet/ESGMYC webinar on “endTB-Q trial: a short treatment regimen for pre-XDR TB?”
Please register for this webinar in advance using the link below:
After registering, you will receive a confirmation email containing information about joining the webinar
Contact information: admin@tbnet.eu
About the webinar:
endTB-Q is a Phase III, randomized controlled clinical trial testing a 6-9-month, all-oral regimen for the treatment of rifampicin-resistant, fluoroquinolone-susceptible tuberculosis (or pre-XDR-TB). endTB-Q features a personalized medicine design, where treatment duration in the experimental arm is defined according to baseline extent of TB disease and early treatment response. This webinar will outline the main efficacy and safety results of the trial, with a particular focus on stratification by baseline disease extent.
Speakers:
Lorenzo Guglielmetti, Médecins Sans Frontières, France
Lorenzo Guglielmetti, MD, PhD, is an infectious diseases physician and epidemiologist with a strong focus on clinical research to improve the treatment of drug-resistant TB. He is a clinician and researcher at the National Reference Center for Mycobacteria (Pitié-Salpêtrière Hospital, Paris, France) and director of the endTB project for Médecins Sans Frontières. He is Chair of the ESCMID Study Group on Mycobacterial Infections (ESGMYC) and part of the Steering Committee of the TBnet.
Francis Varaine, Médecins Sans Frontières, France
Francis Varaine, MD, is a physician with a long field experience with Médecins Sans Frontières. He was chairman of the MSF Tuberculosis Working Group that gathers expertise and coordinates various actors of TB management within MSF: clinicians, pharmacists, biologists, and epidemiologists from MSF operational centers. He was the initiator and director for MSF of the endTB project. He is co-Investigator in the endTB trials.
Chair:
Gunar Günther, University of Bern, Switzerland
Gunar Günther, MD, PhD, is a pulmonologist, currently working at Inselspital, Hospital of the University of Bern (Switzerland) and Katatura State Hospital / School of Medicine of the University of Namibia (Windhoek, Namibia). Gunar is member of TBnet since 2008 and has a strong interest in capacity building, operational research and clinical TB care in Europe and Africa.He is the vice chair of TBnet since 2023.
Comments